Received:06 November 2019,
Published:30 March 2020
移动端阅览
Junfeng ZHANG, Zhiping ZHAO, Huan QIN, et al. Copine 8 promotes proliferation, invasion and metastasis of pancreatic cancer[J]. Journal of Third Military Medical University, 2020, 42(6): 601-610.
Junfeng ZHANG, Zhiping ZHAO, Huan QIN, et al. Copine 8 promotes proliferation, invasion and metastasis of pancreatic cancer[J]. Journal of Third Military Medical University, 2020, 42(6): 601-610. DOI: 10.16016/j.1000-5404.201911042.
Objective
2
To explore the biological role of copine 8 in the occurrence and progression of pancreatic cancer.
Methods
2
GEO datasets were used to compare the expression of copine 8 in pancreatic cancer tissues and adjacent tissues
and TCGA datasets were used to analyze the impact of copine 8 expression on the patients' overall survival rate. The differentially expressed genes between the patients with high and low copine 8 expression were analyzed using GO
KEGG enrichment analysis and gene set enrichment analysis (GSEA). The effect of small interfering RNA-mediated silencing of copine 8 on proliferation
invasion
metastasis
and apoptosis of pancreatic cancer cell lines CFPAC-1 and AsPC-1 were examined using CCK8 assay
colony formation assay
transwell assay
and Annexin V-FITC and propidium iodide staining. The pancreatic cancer transcriptome dataset was analyzed to identify the pathways regulated by copine 8.
Results
2
Copine 8 mRNA and protein were highly expressed in pancreatic cancer tissues and lowly expressed in adjacent tissues. Copine 8 expression was significantly correlated with the survival prognosis of the patients with pancreatic cancer (
P
=0.033). Enrichment analysis showed that copine 8 affected WNT
Hippo
mTOR
and ERBB signaling pathways in pancreatic cancer
and may promote the progression of pancreatic cancer by affecting the expression of the key molecules YAP1
STK3
STK4 and SGMS1 in Hippo pathway. Interference of copine 8 expression significantly suppressed the proliferation
invasion and migration and obviously increased the number of apoptotic cells in 2 pancreatic cancer cell lines.
Conclusion
2
Copine 8 has a strong cancer-promoting effect and plays a significant role in the proliferation
invasion
metastasis and apoptosis of pancreatic cancer.
Global Burden Of Disease Cancer Collaboration FITZMAURICE C ABATE D Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study JAMA Oncol 2019 5 12 1749 1768 10.1001/jamaoncol.2019.2996 Global Burden Of Disease Cancer Collaboration, FITZMAURICE C, ABATE D, et al . Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol, 2019, 5(12): 1749-1768. DOI: 10.1001/jamaoncol.2019.2996.
KAMISAWA T WOOD L D ITOI T Pancreatic cancer Lancet 2016 388 10039 73 85 10.1016/s0140-6736(16)00141-0 KAMISAWA T, WOOD L D, ITOI T, et al . Pancreatic cancer. Lancet, 2016, 388(10039): 73-85. DOI: 10.1016/s0140-6736(16)00141-0.
TSAI S EVANS D B Therapeutic advances in localized pancreatic cancer JAMA Surg 2016 151 9 862 868 10.1001/jamasurg.2016.1113 TSAI S, EVANS D B. Therapeutic advances in localized pancreatic cancer. JAMA Surg, 2016, 151(9): 862-868. DOI: 10.1001/jamasurg.2016.1113.
CREUTZ C E TOMSIG J L SNYDER S L Thecopines, a novel class of C2 domain-containing, calcium-dependent, phospholipid-binding proteins conserved from Paramecium to humans J Biol Chem 1998 273 3 1393 1402 10.1074/jbc.273.3.1393 CREUTZ C E, TOMSIG J L, SNYDER S L, et al . Thecopines, a novel class of C2 domain-containing, calcium-dependent, phospholipid-binding proteins conserved from Paramecium to humans. J Biol Chem, 1998, 273(3): 1393-1402. DOI: 10.1074/jbc.273.3.1393.
JIANG Z H JIANG J N ZHAO B Z CPNE1 silencing inhibits the proliferation, invasion and migration of human osteosarcoma cells Oncol Rep 2018 39 2 643 650 10.3892/or.2017.6128 JIANG Z H, JIANG J N, ZHAO B Z, et al . CPNE1 silencing inhibits the proliferation, invasion and migration of human osteosarcoma cells.Oncol Rep, 2018, 39(2): 643-650. DOI: 10.3892/or.2017.6128.
PARICHARTTANAKUL N M SAHARAT K CHOKCHAIC-HAMNANKIT D Unveiling a novel biomarker panel for diagnosis and classification of well-differentiated thyroid carcinomas Oncol Rep 2016 35 4 2286 2296 10.3892/or.2016.4567 PARICHARTTANAKUL N M, SAHARAT K, CHOKCHAIC-HAMNANKIT D, et al . Unveiling a novel biomarker panel for diagnosis and classification of well-differentiated thyroid carcinomas. Oncol Rep, 2016, 35(4): 2286-2296. DOI: 10.3892/or.2016.4567.
BAEK M AHN T KANG D CPNE7 as prognostic factor and therapeutic target in colorectal cancer Ann Surg Oncol 2018 25 1 S154 10.1245/s10434-018-6349-1 BAEK M, AHN T, KANG D, et al . CPNE7 as prognostic factor and therapeutic target in colorectal cancer. Ann Surg Oncol, 2018, 25(1): S154. DOI: 10.1245/s10434-018-6349-1.
JEONG D BAN S KIM H Abstract 4455: Identification of novel oncogene, copine-7 (CPNE7), in colorectal cancer Cancer Res 2017 77 13 4455 10.1158/1538-7445.am2017-4455 JEONG D, BAN S, KIM H, et al . Abstract 4455: Identification of novel oncogene, copine-7 (CPNE7), in colorectal cancer. Cancer Res, 2017, 77(13): 4455. DOI: 10.1158/1538-7445.am2017-4455.
PAN H X XU X J WU D Y Novel somatic mutations identified by whole-exome sequencing in muscle-invasive transitional cell carcinoma of the bladder Oncol Lett 2016 11 2 1486 1492 10.3892/ol.2016.4094 PAN H X, XU X J, WU D Y, et al . Novel somatic mutations identified by whole-exome sequencing in muscle-invasive transitional cell carcinoma of the bladder.Oncol Lett, 2016, 11(2): 1486-1492. DOI: 10.3892/ol.2016.4094.
LIN H C ZHANG F L GENG Q Quantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC J Proteome Res 2013 12 7 3423 3433 10.1021/pr400273z LIN H C, ZHANG F L, GENG Q, et al . Quantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC. J Proteome Res, 2013, 12(7): 3423-3433. DOI: 10.1021/pr400273z.
SAKTHIVEL K M PRABHU VV Copine 3 as a novel potential drug target for non-small-cell lung carcinoma J Environ Pathol Toxicol Oncol 2017 36 2 107 112 10.1615/JEnvironPatholToxicolOncol.2017019540 SAKTHIVEL K M, PRABHU VV. Copine 3 as a novel potential drug target for non-small-cell lung carcinoma. J Environ Pathol Toxicol Oncol, 2017, 36(2): 107-112. DOI: 10.1615/JEnvironPatholToxicolOncol.2017019540.
CHOI H Y PARK N NA J B Direct binding of Copine3 with Jab1 activates downstream ErbB2 signaling and motility in SKBr3 breast cancer cells Oncol Rep 2016 35 2 1147 1152 10.3892/or.2015.4472 CHOI H Y, PARK N, NA J B, et al . Direct binding of Copine3 with Jab1 activates downstream ErbB2 signaling and motility in SKBr3 breast cancer cells.Oncol Rep, 2016, 35(2): 1147-1152. DOI: 10.3892/or.2015.4472.
HEINRICH C KELLER C BOULAY A Copine-Ⅲ interacts with ErbB2 and promotes tumor cell migration Oncogene 2010 29 11 1598 1610 10.1038/onc.2009.456 HEINRICH C, KELLER C, BOULAY A, et al . Copine-Ⅲ interacts with ErbB2 and promotes tumor cell migration. Oncogene, 2010, 29(11): 1598-1610. DOI: 10.1038/onc.2009.456.
RAMSEY H ZHANG D E RICHKIND K Fusion of AML1/Runx1 tocopine Ⅷ, a novel member of the copine family, in an aggressive acute myelogenous leukemia with t(12;21) translocation Leukemia 2003 17 8 1665 1666 10.1038/sj.leu.2403048 RAMSEY H, ZHANG D E, RICHKIND K, et al . Fusion of AML1/Runx1 tocopine Ⅷ, a novel member of the copine family, in an aggressive acute myelogenous leukemia with t(12;21) translocation. Leukemia, 2003, 17(8): 1665- 1666. DOI: 10.1038/sj.leu.2403048.
MCGUIGAN A KELLY P TURKINGTON R C Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes World J Gastroenterol 2018 24 43 4846 4861 10.3748/wjg.v24.i43.4846 MCGUIGAN A, KELLY P, TURKINGTON R C, et al . Pancreatic cancer: a review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol, 2018, 24(43): 4846-4861. DOI: 10.3748/wjg.v24.i43.4846.
DRAPER A Updates in pancreatic cancer: Modest gains andhopeful targets J Oncol Pharm Pract 2019 25 1 101 109 10.1177/1078155218763035 DRAPER A. Updates in pancreatic cancer: Modest gains andhopeful targets. J Oncol Pharm Pract, 2019, 25(1): 101-109. DOI: 10.1177/1078155218763035.
CAO X M Role of miR-337-3p and its target Rap1A inmodulating proliferation, invasion, migration and apoptosis of cervical cancer cells Cancer Biomark 2019 24 3 257 267 10.3233/CBM-181225 CAO X M. Role of miR-337-3p and its target Rap1A inmodulating proliferation, invasion, migration and apoptosis of cervical cancer cells. Cancer Biomark, 2019, 24(3): 257-267. DOI: 10.3233/CBM-181225.
SONG Q CHEN Q WANG Q M ATF-3/miR-590/GOLPH3 signaling pathwayregulates proliferation of breast cancer BMC Cancer 2018 18 1 255 10.1186/s12885-018-4031-4 SONG Q, CHEN Q, WANG Q M, et al . ATF-3/miR-590/GOLPH3 signaling pathwayregulates proliferation of breast cancer. BMC Cancer, 2018, 18(1): 255. DOI: 10.1186/s12885-018-4031-4.
LU G H SHI W L ZHENG H Y Inhibition of STAT6/anoctamin-1 activation suppresses proliferation and invasion of gastric cancer cells Cancer Biother Radiopharm 2018 33 1 3 7 10.1089/cbr.2017.2287 LU G H, SHI W L, ZHENG H Y. Inhibition of STAT6/anoctamin-1 activation suppresses proliferation and invasion of gastric cancer cells. Cancer Biother Radiopharm, 2018, 33(1): 3-7. DOI: 10.1089/cbr.2017.2287.
QIN Y HU Q S JI S R Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc Axis in pancreatic cancer Cell Prolif 2019 52 3 e12603 10.1111/cpr.12603 QIN Y, HU Q S, JI S R, et al . Homeodomain-interacting protein kinase 2 suppresses proliferation and aerobic glycolysis via ERK/cMyc Axis in pancreatic cancer. Cell Prolif, 2019, 52(3): e12603. DOI: 10.1111/cpr.12603.
WANG J WANG B REN H Q MiR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1 Biochem Biophys Res Commun 2019 509 1 241 248 10.1016/j.bbrc.2018.12.114 WANG J, WANG B, REN H Q, et al . MiR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1.Biochem Biophys Res Commun, 2019, 509(1): 241-248. DOI: 10.1016/j.bbrc.2018.12.114.
SUN X C ZHANG Y LI B S MTA1 promotes the invasion and migration of pancreatic cancer cells potentially through the HIF-α/VEGF pathway J Recept Signal Transduct Res 2018 38 4 352 358 10.1080/10799893.2018.1531887 SUN X C, ZHANG Y, LI B S, et al . MTA1 promotes the invasion and migration of pancreatic cancer cells potentially through the HIF-α/VEGF pathway. J Recept Signal Transduct Res, 2018, 38(4): 352-358. DOI: 10.1080/10799893.2018.1531887.
ZHONG Z W ZHOU F WANG D Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines Oncol Rep 2018 40 6 3852 3860 10.3892/or.2018.6760 ZHONG Z W, ZHOU F, WANG D, et al . Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines.Oncol Rep, 2018, 40(6): 3852-3860. DOI: 10.3892/or.2018.6760.
ANSARI D OHLSSON H ALTHINI C The hippo signaling pathway in pancreatic cancer Anticancer Res 2019 39 7 3317 3321 10.21873/anticanres.13474 ANSARI D, OHLSSON H, ALTHINI C, et al . The hippo signaling pathway in pancreatic cancer. Anticancer Res, 2019, 39(7): 3317-3321. DOI: 10.21873/anticanres.13474.
EIBL G ROZENGURT E KRAS, YAP, and obesity in pancreatic cancer: a signaling network with multiple loops Semin Cancer Biol 2019 54 50 62 10.1016/j.semcancer.2017.10.007 EIBL G, ROZENGURT E. KRAS, YAP, and obesity in pancreatic cancer: a signaling network with multiple loops. Semin Cancer Biol, 2019, 54: 50-62. DOI: 10.1016/j.semcancer.2017.10.007.
CHEN M Y WANG M XU S M Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway Oncotarget 2015 6 42 44466 44479 10.18632/oncotarget.6298 CHEN M Y, WANG M, XU S M, et al .Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway. Oncotarget, 2015, 6(42): 44466-44479. DOI: 10.18632/oncotarget.6298.
ZHANG M T ZHAO Y ZHANG Y L LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway Biochim Biophys Acta Mol Basis Dis 2018 1864 5 Pt A 1770 1782 10.1016/j.bbadis.2018.03.005 ZHANG M T, ZHAO Y, ZHANG Y L, et al .LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(5 Pt A): 1770-1782. DOI: 10.1016/j.bbadis.2018.03.005.
JIANG Z D ZHOU CC CHENG L Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions J Exp Clin Cancer Res 2018 37 1 69 10.1186/s13046-018-0740-4 JIANG Z D, ZHOU CC, CHENG L, et al . Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions. J Exp Clin Cancer Res, 2018, 37(1): 69. DOI: 10.1186/s13046-018-0740-4.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
